Expanding TB prevention could save millions of lives and yield major economic benefits, global study finds
An international study led by Jonathon Campbell at The Institute highlights the powerful health and economic impact of…
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Teva Pharmaceutical Industries Ltd FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in…